London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

Adelaide nurse and mother-of-two Deanne Tingey thought her little girl, Winter, was just suffering from a common cold.

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

EMA accepts for regulatory review GSK’s RSV vaccine, Arexvy to expand use in adults 18 years and older: London, UK Saturday, June 14, 2025, 10:00 Hrs [IST] GSK plc announced tha ...

It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

Arexvy was the first RSV vaccine approved in the European Economic Area for the prevention of lower respiratory tract disease caused by RSV in adults aged 60 and older, and for those aged 50 to 59 ...

People in Northern Ireland are being reminded that a potentially life-saving vaccination aimed at protecting newborns and ...

Nothing can bum out a summer vacation like a trip to the emergency room. Follow these tips to stay safe while having fun.

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.